dipyridamole has been researched along with Thrombosis in 314 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Large-scale clinical trials of the use of aspirin in post-myocardial infarction patients were based on the assumption that inhibition of platelet activity would reduce thromboembolism associated with atherosclerosis, and that thromboembolism is a major cause of the clinical complications of atherosclerosis." | 6.15 | Aspirin in the treatment of cardiovascular disease: a review. ( Kinlough-Rathbone, RL; Mustard, JF; Packham, MA, 1983) |
| "A review is given on the clinical studies performed with aspirin in patients with chronic vascular occlusions of the limbs and on studies in cerebral ischemia using aspirin and sulfinpyrazone." | 6.14 | Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders. ( Breddin, K, 1977) |
| "Ellagic acid trebled mean thrombus weight and ASA/D reduced this by 49%, but did not restore normality." | 5.29 | Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals. ( Iomhair, MM; Lavelle, SM, 1996) |
| " We give an overview of several new antiplatelet agents that are currently investigated in secondary stroke prevention: adenosine 5'-diphosphonate receptor antagonists, cilostazol, sarpogrelate, terutroban and SCH 530348." | 4.86 | Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention. ( Diener, HC; Weber, R, 2010) |
| "Appropriate oral first-line antiplatelet therapy is aspirin for individuals with ST-segment elevation myocardial infarction; aspirin or clopidogrel for those with TIA or stroke, chronic stable angina, or peripheral arterial disease; and aspirin combined with clopidogrel for those with non-ST-segment elevation acute coronary syndrome." | 4.82 | Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004) |
| "High-dose ASA in Heart Mate II patients treated concomitantly with warfarin is associated with an increased hazard of bleeding but does not reduce thrombotic events." | 3.83 | Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support. ( D'Alessandro, D; Goldstein, DJ; Guerrero, C; Jermyn, R; Jorde, UP; Kargoli, F; Levin, AP; Madan, S; Nguyen, J; Patel, SR; Saeed, O; Shah, A; Shin, J; Sims, DB, 2016) |
| "Platelet deposition and thrombus formation caused by angioplasty appear to be important in the development of 2 complications: acute thrombotic occlusion and restenosis." | 3.76 | Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. ( Harker, LA, 1987) |
| "Hydroxychloroquine was effective in reducing postoperative venous thrombosis in patients undergoing general abdominothoracic surgery but the evidence that it was effective in patients undergoing orthopaedic surgery is inconclusive." | 3.75 | Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. ( Turpie, AG, 1982) |
| "Two highly sensitive models of arterial and venous thrombosis forming with the test of endothelial stability a complementary system with a maximum stress on the role of vascular lesion were used to test a series of four antithrombotic drugs (heparin, acetylsalicylic acid, dipyridamole, sulfinpyrazone) and four drugs with other indications but with an antithrombotic activity in experiment (prenylamine, troxerutin, ketanserin and pizotifen)." | 3.67 | Antithrombotics in view of thrombosis models. ( Hladovec, J, 1986) |
| "A series of 1,4-dihydropyridines (DHP) bound to 1,2-benzisothiazol-3-ones were synthesized and evaluated for their ability to inhibit platelet aggregation induced by collagen in human platelet-rich plasma (PRP) and to protect mice against experimental thrombosis." | 3.67 | Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines. ( Cillero, FJ; Fau de Casa-Juana, M; Ortega, MP; Priego, JG; Sunkel, CE, 1988) |
| "Treatment with dipyridamole plus aspirin had a significant but modest effect in reducing the risk of stenosis and improving the duration of primary unassisted patency of newly created grafts." | 2.74 | Effect of dipyridamole plus aspirin on hemodialysis graft patency. ( Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Fenves, AZ; Gassman, JJ; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kaufman, JS; Kusek, JW; Lawson, JH; Martin, KJ; McNeil, JW; Meyers, CM; Radeva, MK; Rahman, A; Vazquez, MA; Whiting, JF, 2009) |
| "Graft thrombosis is a well-recognised complication of solid organ transplantation and is one of the leading causes of graft failure." | 2.72 | Interventions for preventing thrombosis in solid organ transplant recipients. ( Hanley, J; Hoather, TJ; Surianarayanan, V; Thompson, ER; Tingle, SJ; Wilson, CH, 2021) |
| "Arterial thrombus formation was induced ex vivo by exposing a collagen-coated surface in a parallel-plate perfusion chamber to native blood for 3 min (arterial wall shear rate 2600 s(-1))." | 2.71 | Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. ( Boneu, B; Cadroy, Y; Sakariassen, K; Thalamas, C, 2005) |
| "Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
| "Seven of nine patients (78%) developed thrombus; five had thrombus visible within the clear housing of the device during the implant period, and two patients had thrombus discovered only after VAD explantation." | 2.66 | Thromboembolic complications of the Symbion AVAD System. ( Cleavinger, M; Copeland, JG; Icenogle, TB; Sethi, GK; Smith, RG; Vasu, MA; Williams, RJ, 1989) |
| "For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched June 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 5)." | 2.52 | Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. ( Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH, 2015) |
| "Here dipyridamole was experimentally shown to improve perfusion and function in chronic hypoperfused tissue unrelated to its vasodilatory properties." | 2.48 | Dipyridamole in antithrombotic treatment. ( Eisert, WG, 2012) |
| "Aspirin has stood the test of time over decades as the gold standard for relatively effective, safe, and inexpensive antiplatelet therapy." | 2.40 | Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. ( Schafer, AI, 1997) |
| "As predicted, DIP-FU-PPy NPs prevented thrombus recurrence and emitted visible fluorescence signals during thrombus clot penetration with no adverse effects." | 1.91 | P-Selectin mediates targeting of a self-assembling phototherapeutic nanovehicle enclosing dipyridamole for managing thromboses. ( Chen, YT; Chuang, EY; Godugu, C; Jheng, PR; Lee, CY; Liu, CH; Nguyen, HT; Rethi, L, 2023) |
| "Counterproductive lung inflammation and dysregulated thrombosis contribute importantly to the lethality of advanced COVID-19." | 1.56 | Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole. ( Barroso-Aranda, J; DiNicolantonio, JJ, 2020) |
| "Dipyridamole is a vasodilator and platelet inhibitor that has previously been shown to have direct antioxidant properties." | 1.33 | The effect of dipyridamole on vascular cell-derived reactive oxygen species. ( Chakrabarti, S; Freedman, JE; Iyu, D; Varghese, S; Vitseva, O, 2005) |
| "Dipyridamole is a potent nontoxic inhibitor of platelet activation/aggregation, and also a strong inhibitor of vascular smooth muscle cell proliferation." | 1.31 | Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. ( Aldenhoff, YB; Habets, J; Koole, LH; Poole-Warren, LA; ter Woorst, J; van Der Veen, FH, 2001) |
| "Hemorrhage was present in 9 cases of group B (21." | 1.30 | [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. ( Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ, 1997) |
| "Dipyridamole is a well-known vasodilator and a powerful inhibitor of activation and aggregation of blood platelets." | 1.30 | Photo-immobilization of dipyridamole (Persantin) at the surface of polyurethane biomaterials: reduction of in-vitro thrombogenicity. ( Aldenhoff, YB; Blezer, R; Koole, LH; Lindhout, T, 1997) |
| "In 2 patients removal of the thrombus at the valve hinges was assisted by the use of a flexible fiberoptic choledochoscope." | 1.29 | Thrombotic obstruction of bileaflet valves: surgical management and fiberoptic thrombectomy. ( al-Halees, Z; Kumar, N, 1994) |
| "Ellagic acid trebled mean thrombus weight and ASA/D reduced this by 49%, but did not restore normality." | 1.29 | Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals. ( Iomhair, MM; Lavelle, SM, 1996) |
| "However, their effects on thrombus formation have rarely been evaluated in experimental animals in vivo." | 1.29 | In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis. ( Iwamoto, Y; Naritomi, H; Nishimura, H; Sugita, M; Tachibana, H, 1996) |
| "Platelet-thrombus formation is a complication of arterial wall deep injury by balloon angioplasty that may lead to acute arterial occlusion and may contribute to restenosis." | 1.28 | Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs. ( Badimon, L; Chesebro, JH; Fuster, V; Heras, M; Lam, JY; Steele, PM; Webster, MW, 1991) |
| "Similarly, a pronounced inhibition of thrombus formation was observed by in vivo microscopy and computer-assisted morphometric analysis, after oral treatment of non-anesthetized hamsters with dipyridamole, 5 mg/kg." | 1.28 | Dipyridamole--evaluation of an established antithrombotic drug in view of modern concepts of blood cell-vessel wall interactions. ( Eisert, WG; Müller, TH, 1990) |
| "The mean value of the thrombus area in the dilazep group was 60% smaller and the distribution pattern of the thrombus by size was found to be composed of smaller thrombi than those of the control group." | 1.28 | Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits. ( Asanuma, A; Fujii, M; Nobuyoshi, M; Takimoto, M; Tanaka, M, 1989) |
| "Venous thrombosis was prevented in groups II (p less than 0." | 1.28 | [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs]. ( Alvarez, L; Castillo-Olivares, JL; de Haro, J; Escudero, MC; Millán, I; Rodríguez, V, 1989) |
| "When the mural thrombus was removed from 14 grafts, a median 73% of the platelets were located in the interface between thrombus and graft." | 1.27 | Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs. ( Chesebro, JH; Dewanjee, MK; Fuster, V; Kaye, MP; Pumphrey, CW; Vlietstra, RE, 1983) |
| "A patient with a right atrial thrombus and recurrent pulmonary emboli secondary to permanent pacemaker insertion is described." | 1.27 | Right atrial thrombus and recurrent pulmonary emboli secondary to permanent cardiac pacing--a case report and short review of literature. ( Avnun, L; Hirsch, M; Ovsyshcher, I; Porath, A, 1987) |
| "Graft success was evaluated by patency, thrombus-free surface area, area endothelialized, and graft production of prostacyclin." | 1.27 | Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model. ( Evancho, MM; Falkow, LJ; Hunter, TJ; Schmidt, SP; Sharp, WV, 1985) |
| " Possible explanations for these negative findings include inadequate dosage or form of omega-3 fatty acids and the antiplatelet drugs administered, excessive variability in graft response due to uncharacterized immunologic histocompatibility, and the possible influence of non-platelet-mediated mechanisms." | 1.27 | Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts. ( DeCampli, WM; Handen, CE; Kosek, JC; Miller, DC; Mitchell, RS, 1988) |
| "Trapidil was expected to be an effective antithrombotic agent." | 1.26 | Antithrombotic activity and the mechanism of action of trapidil (Rocornal). ( Kitamura, Y; Ohnishi, H; Shimada, S; Suzuki, Y; Yamaguchi, K, 1982) |
| " Optimum drug or combination of drugs and dosage are still controversial." | 1.26 | [Inhibition of platelet function in pediatric medicine (author's transl)]. ( Schmidt, B, 1982) |
| "In patients with transient ischemic attacks, particularly males with appropriate carotid lesions, aspirin therapy reduces the frequency of transient ischemic attacks and possibly the incidence of stroke and death." | 1.26 | [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. ( Oelz, O, 1979) |
| "Heparin reduced thrombus only when sufficient was given to reduce blood coagulation." | 1.26 | Effects of heparin, aspirin and dipyridamole on thrombus formation on venous catheters. ( Hecker, JF; Spanos, HG, 1979) |
| "Platelet adhesion and thrombus formation were compared after perfusion of native blood and of blood anticoagulated with citrate, heparin or heparin plus citrate." | 1.26 | Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood. ( Baumgartner, HR, 1979) |
| "and sulfinpyrazone have been tested in several large scale clinical trials." | 1.26 | [Antiplatelet drugs (author's transl)]. ( Dechavanne, M; Follea, G; Trzeciak, MC, 1979) |
| "Aspirin was about twice as less active than KC-6141 and dipyridamole showed no effect on the thrombosis." | 1.26 | Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats. ( Sanai, K; Umetsu, T, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 237 (75.48) | 18.7374 |
| 1990's | 31 (9.87) | 18.2507 |
| 2000's | 25 (7.96) | 29.6817 |
| 2010's | 14 (4.46) | 24.3611 |
| 2020's | 7 (2.23) | 2.80 |
| Authors | Studies |
|---|---|
| Sunkel, CE | 1 |
| Fau de Casa-Juana, M | 1 |
| Cillero, FJ | 1 |
| Priego, JG | 1 |
| Ortega, MP | 2 |
| Liu, CH | 1 |
| Jheng, PR | 1 |
| Rethi, L | 1 |
| Godugu, C | 1 |
| Lee, CY | 1 |
| Chen, YT | 1 |
| Nguyen, HT | 1 |
| Chuang, EY | 1 |
| Kanthi, Y | 1 |
| Knight, JS | 1 |
| Zuo, Y | 1 |
| Pinsky, DJ | 1 |
| Berthelot, JM | 1 |
| Drouet, L | 1 |
| Lioté, F | 1 |
| DiNicolantonio, JJ | 1 |
| Barroso-Aranda, J | 1 |
| Martin, NK | 1 |
| Domínguez-Robles, J | 1 |
| Stewart, SA | 1 |
| Cornelius, VA | 1 |
| Anjani, QK | 1 |
| Utomo, E | 1 |
| García-Romero, I | 1 |
| Donnelly, RF | 1 |
| Margariti, A | 1 |
| Lamprou, DA | 1 |
| Larrañeta, E | 1 |
| Hampton, T | 1 |
| Surianarayanan, V | 1 |
| Hoather, TJ | 1 |
| Tingle, SJ | 1 |
| Thompson, ER | 1 |
| Hanley, J | 1 |
| Wilson, CH | 1 |
| Liu, Y | 1 |
| Oh, SJ | 1 |
| Chang, KH | 1 |
| Kim, YG | 1 |
| Lee, MY | 1 |
| Dodd, JM | 2 |
| McLeod, A | 2 |
| Windrim, RC | 2 |
| Kingdom, J | 2 |
| Bedenis, R | 1 |
| Lethaby, A | 1 |
| Maxwell, H | 1 |
| Acosta, S | 1 |
| Prins, MH | 1 |
| Saeed, O | 1 |
| Shah, A | 1 |
| Kargoli, F | 1 |
| Madan, S | 1 |
| Levin, AP | 1 |
| Patel, SR | 1 |
| Jermyn, R | 1 |
| Guerrero, C | 1 |
| Nguyen, J | 1 |
| Sims, DB | 1 |
| Shin, J | 1 |
| D'Alessandro, D | 1 |
| Goldstein, DJ | 1 |
| Jorde, UP | 1 |
| Sandner, SE | 1 |
| Zimpfer, D | 1 |
| Zrunek, P | 1 |
| Steinlechner, B | 1 |
| Rajek, A | 1 |
| Schima, H | 1 |
| Wolner, E | 1 |
| Wieselthaler, GM | 1 |
| Dixon, BS | 2 |
| Beck, GJ | 2 |
| Vazquez, MA | 2 |
| Greenberg, A | 2 |
| Delmez, JA | 2 |
| Allon, M | 2 |
| Dember, LM | 2 |
| Himmelfarb, J | 3 |
| Gassman, JJ | 1 |
| Greene, T | 2 |
| Radeva, MK | 2 |
| Davidson, IJ | 2 |
| Ikizler, TA | 2 |
| Braden, GL | 2 |
| Fenves, AZ | 1 |
| Kaufman, JS | 1 |
| Cotton, JR | 2 |
| Martin, KJ | 1 |
| McNeil, JW | 1 |
| Rahman, A | 1 |
| Lawson, JH | 2 |
| Whiting, JF | 1 |
| Hu, B | 2 |
| Meyers, CM | 1 |
| Kusek, JW | 2 |
| Feldman, HI | 2 |
| Lok, CE | 1 |
| Zettl, H | 1 |
| Schubert-Zsilavecz, M | 1 |
| Weale, AR | 1 |
| Cooper, DG | 1 |
| Hentschel, DM | 1 |
| Weber, R | 1 |
| Diener, HC | 1 |
| De Caterina, R | 1 |
| Massaro, M | 1 |
| Scoditti, E | 1 |
| Annunziata Carluccio, M | 1 |
| Bech, FR | 1 |
| Chertow, GM | 1 |
| Gresele, P | 1 |
| Momi, S | 1 |
| Falcinelli, E | 1 |
| Eikelboom, JW | 2 |
| Hirsh, J | 10 |
| Spencer, FA | 1 |
| Baglin, TP | 1 |
| Weitz, JI | 1 |
| Bassareo, PP | 1 |
| Fanos, V | 1 |
| Iacovidou, N | 1 |
| Mercuro, G | 1 |
| Salava, A | 1 |
| Alanko, K | 1 |
| Hyry, H | 1 |
| Eisert, WG | 4 |
| Lecompte, T | 2 |
| Hankey, GJ | 1 |
| Kopp, CW | 1 |
| Steiner, S | 1 |
| Priglinger, U | 1 |
| Christ, G | 1 |
| Probst, P | 1 |
| Maurer, G | 1 |
| Minar, E | 1 |
| Huber, K | 1 |
| CASELLAS BERNAT, A | 1 |
| TRILLA SANCHEZ, E | 1 |
| DE-VOS BERRUETA, M | 1 |
| GAUSI GENE, C | 1 |
| Rao, U | 1 |
| Weston, C | 1 |
| Tran, H | 1 |
| Anand, SS | 1 |
| Iagoda, AV | 1 |
| Koroĭ, PV | 1 |
| Cadroy, Y | 1 |
| Thalamas, C | 1 |
| Sakariassen, K | 1 |
| Boneu, B | 1 |
| Chakrabarti, S | 1 |
| Vitseva, O | 1 |
| Iyu, D | 1 |
| Varghese, S | 1 |
| Freedman, JE | 1 |
| Born, G | 1 |
| Patrono, C | 2 |
| Fontana, P | 1 |
| Meadows, TA | 1 |
| Bhatt, DL | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| McNicol, GP | 1 |
| de Gaetano, G | 2 |
| Cerletti, C | 1 |
| Bertelè, V | 1 |
| Kelton, JG | 3 |
| Weichert, W | 2 |
| Pauliks, V | 1 |
| Breddin, HK | 2 |
| Buckler, P | 1 |
| Douglas, AS | 3 |
| Harjola, PT | 2 |
| Frick, MH | 1 |
| Meurala, H | 2 |
| Valle, M | 1 |
| Bergqvist, D | 1 |
| Stanley, JC | 1 |
| Burkel, WE | 1 |
| Ford, JW | 1 |
| Vinter, DW | 1 |
| Kahn, RH | 1 |
| Whitehouse, WM | 1 |
| Graham, LM | 1 |
| Goldman, MD | 1 |
| Simpson, D | 1 |
| Hawker, RJ | 3 |
| Norcott, HC | 2 |
| McCollum, CN | 5 |
| Kester, RC | 2 |
| Hansen, MS | 2 |
| Birgens, HS | 2 |
| Koiso, K | 1 |
| Akima, H | 1 |
| Niijima, T | 1 |
| Suzuki, Y | 1 |
| Yamaguchi, K | 1 |
| Shimada, S | 1 |
| Kitamura, Y | 1 |
| Ohnishi, H | 1 |
| Kher, A | 1 |
| Gaillard, JL | 1 |
| Samama, M | 1 |
| Chesebro, JH | 9 |
| Fuster, V | 12 |
| Louie, S | 1 |
| Gurewich, V | 2 |
| Breddin, K | 4 |
| Loeliger, EA | 4 |
| Mustard, JF | 7 |
| Kinlough-Rathbone, RL | 7 |
| Packham, MA | 6 |
| Goldman, M | 3 |
| Hall, C | 1 |
| Dykes, J | 1 |
| Rhyner, K | 1 |
| Stenger, M | 1 |
| Block, LH | 1 |
| Lewis, GP | 1 |
| Smith, JR | 1 |
| Crow, MJ | 2 |
| Rajah, SM | 3 |
| Lucas, MA | 1 |
| Takayama, T | 3 |
| Kumashiro, R | 2 |
| Pavlides, CA | 1 |
| Kholoussy, AM | 2 |
| Matsumoto, T | 2 |
| Stratton, JR | 2 |
| Ritchie, JL | 1 |
| Salter, MC | 1 |
| Donaldson, DR | 1 |
| Roberts, TG | 1 |
| Davison, AM | 1 |
| Karczewiczowa, D | 1 |
| Krzystolikowa, Z | 1 |
| Rafiqi, EI | 1 |
| Drolc, Z | 1 |
| Verstraete, M | 2 |
| Polli, EE | 1 |
| Cortellaro, M | 1 |
| Reggiani, E | 1 |
| Odaglia, G | 1 |
| Pumphrey, CW | 2 |
| Dewanjee, MK | 3 |
| Vlietstra, RE | 2 |
| Kaye, MP | 4 |
| Gaudiani, VA | 1 |
| Miller, DC | 2 |
| Kosek, JC | 2 |
| Burg, J | 1 |
| Jamieson, SW | 1 |
| Kazmier, FJ | 2 |
| Littlejohn, GO | 1 |
| Deck, JH | 1 |
| Reynolds, WJ | 1 |
| Pirk, J | 1 |
| Ruzbarský, V | 1 |
| König, J | 1 |
| Krajícek, M | 1 |
| Pavel, P | 1 |
| Firt, P | 1 |
| Hancock, JB | 1 |
| Forshaw, PL | 1 |
| Josa, M | 1 |
| Lie, JT | 1 |
| Bianco, RL | 1 |
| Castaigne, A | 1 |
| Benghozi, R | 1 |
| Bienvenu, MP | 1 |
| Mitchell, JR | 6 |
| Weiss, HJ | 4 |
| Vane, JR | 2 |
| Moncada, S | 4 |
| Mayer, JE | 2 |
| Lindsay, WG | 1 |
| Castaneda, W | 1 |
| Nicoloff, DM | 1 |
| Turpie, AG | 3 |
| Groves, HM | 1 |
| Cazenave, JP | 1 |
| Dejana, E | 1 |
| Richardson, M | 2 |
| Clements, IP | 1 |
| Elveback, LR | 1 |
| Smith, HC | 1 |
| Bardsley, WT | 1 |
| Frye, RL | 1 |
| Holmes, DR | 1 |
| Pluth, JR | 1 |
| Wallace, RB | 1 |
| Puga, FJ | 1 |
| Orszulak, TA | 1 |
| Piehler, JM | 1 |
| Schaff, HV | 2 |
| Danielson, GK | 1 |
| Salzman, EW | 2 |
| Marshall, M | 1 |
| Schmidt, B | 1 |
| Murphy, KP | 1 |
| Rosemark, JA | 1 |
| Fuster, VD | 1 |
| Dujovny, M | 1 |
| Kossovsky, N | 1 |
| Loubeau, JM | 1 |
| Nelson, D | 1 |
| McManus, G | 1 |
| Jacobi, E | 1 |
| Bremer, G | 1 |
| Richter, O | 1 |
| Cottafava, F | 1 |
| Brida Di Priò, S | 1 |
| Buono, S | 1 |
| Nardelli, E | 1 |
| Della Casa, C | 1 |
| Boeri, L | 1 |
| Dodero, P | 1 |
| Kahn, SB | 1 |
| Schott, G | 2 |
| Li, X | 1 |
| Cooley, BC | 2 |
| Fiane, AE | 1 |
| Seem, E | 1 |
| Geiran, O | 1 |
| Lindberg, HL | 1 |
| Wu, ZL | 1 |
| Zhou, KR | 1 |
| Liao, LT | 1 |
| al-Halees, Z | 1 |
| Kumar, N | 1 |
| Sreedhara, R | 1 |
| Lazarus, JM | 1 |
| Hakim, RM | 1 |
| Escudero, MC | 2 |
| Alvarez, L | 3 |
| de Haro, J | 2 |
| Millán, I | 3 |
| Jorge, E | 1 |
| Castillo-Olivares, JL | 3 |
| Bertrán, X | 1 |
| Muchart, J | 1 |
| Planas, R | 1 |
| Real, MI | 1 |
| Ribera, JM | 1 |
| Cabré, E | 1 |
| Menacho, M | 1 |
| Gassull, MA | 1 |
| Nishimura, H | 1 |
| Naritomi, H | 1 |
| Iwamoto, Y | 1 |
| Tachibana, H | 1 |
| Sugita, M | 1 |
| Schafer, AI | 2 |
| Iomhair, MM | 1 |
| Lavelle, SM | 2 |
| Brady, L | 1 |
| Magilavy, D | 1 |
| Black, DD | 1 |
| Aldenhoff, YB | 2 |
| Blezer, R | 1 |
| Lindhout, T | 1 |
| Koole, LH | 2 |
| Hupkens, P | 1 |
| Hillis, GS | 1 |
| Jennings, KP | 1 |
| Iturbe, T | 1 |
| Sánchez, C | 1 |
| Moreno, JA | 1 |
| Olave, T | 1 |
| Azaceta, G | 1 |
| Varo, MJ | 1 |
| Civeira, E | 1 |
| Peleato, J | 1 |
| Cornudella, R | 1 |
| Requena, L | 1 |
| Fariña, C | 1 |
| Barat, A | 1 |
| Nakai, K | 1 |
| Tajima, K | 1 |
| Kishimoto, Y | 1 |
| Katsura, K | 1 |
| Kawamura, M | 1 |
| Yamamoto, Y | 1 |
| Hanada, M | 1 |
| Zen, K | 1 |
| Amakawa, R | 1 |
| Fujimoto, M | 1 |
| Fukuhara, S | 1 |
| Sukavaneshvar, S | 1 |
| Solen, KA | 1 |
| Mohammad, SF | 1 |
| van Der Veen, FH | 1 |
| ter Woorst, J | 1 |
| Habets, J | 1 |
| Poole-Warren, LA | 1 |
| Reller, MD | 1 |
| Coller, B | 1 |
| Dalen, JE | 2 |
| FitzGerald, GA | 1 |
| Gent, M | 4 |
| Roth, G | 1 |
| Nair, GV | 1 |
| Davis, CJ | 1 |
| McKenzie, ME | 1 |
| Lowry, DR | 1 |
| Serebruany, VL | 1 |
| Qawi, I | 1 |
| Robson, SC | 1 |
| Marconi, W | 1 |
| Bartoli, F | 1 |
| Mantovani, E | 1 |
| Pittalis, F | 1 |
| Settembri, L | 1 |
| Cordova, C | 1 |
| Musca, A | 1 |
| Alessandri, C | 1 |
| Loo, J | 1 |
| Lagarde, M | 1 |
| Dechavanne, M | 2 |
| Faergeman, O | 1 |
| Gormsen, J | 1 |
| Meinertz, H | 1 |
| Stahl, D | 2 |
| Thomsen, K | 2 |
| Hou-Jensen, K | 2 |
| Korbut, R | 1 |
| Rubegni, M | 1 |
| Provvedi, D | 1 |
| Bellini, PG | 1 |
| Bandinelli, C | 1 |
| De Mauro, G | 1 |
| Coeugniet, E | 1 |
| Didisheim, P | 4 |
| Frick, U | 1 |
| Frick, G | 1 |
| Aosaki, M | 1 |
| Kitamura, N | 1 |
| Weissbach, G | 1 |
| Harker, LA | 11 |
| Kincaid-Smith, P | 4 |
| Latour, JG | 1 |
| Dmoszyńska-Giannopoulou, A | 1 |
| Pluta, A | 1 |
| McGiff, JC | 1 |
| Slichter, SJ | 4 |
| Sauvage, LR | 2 |
| Priluck, IA | 1 |
| Oelz, O | 1 |
| Rao, S | 1 |
| Ahmad, R | 1 |
| Watson, DA | 1 |
| Spanos, HG | 1 |
| Hecker, JF | 1 |
| Baumgartner, HR | 1 |
| Follea, G | 1 |
| Trzeciak, MC | 1 |
| Rossi, EC | 2 |
| Yasunaga, K | 1 |
| Kauffman, HM | 1 |
| Ekbom, GA | 1 |
| Adams, MB | 1 |
| Hussey, CV | 1 |
| Bruhn, HD | 1 |
| Umetsu, T | 1 |
| Sanai, K | 1 |
| Jobin, F | 1 |
| Pokrovskii, AV | 1 |
| Aleksandrova, NP | 1 |
| Kovalenko, VI | 1 |
| Deykin, D | 1 |
| Genton, E | 3 |
| Gavrilov, OK | 1 |
| Rachinskaia, NA | 1 |
| Kaveshnikova, BF | 1 |
| Aledort, LM | 1 |
| Jacques, C | 1 |
| Drueke, T | 1 |
| Nedellec, J | 1 |
| Kremp, O | 1 |
| Gazengel, C | 1 |
| Köhler, H | 1 |
| Honour, AJ | 5 |
| Hockaday, TD | 1 |
| Mann, JI | 1 |
| Porter, JM | 1 |
| Goodnight, SH | 1 |
| Kasahara, T | 1 |
| Moore, S | 1 |
| Richardson, PD | 1 |
| Galletti, PM | 1 |
| Born, GV | 1 |
| Lipinski, B | 1 |
| Conti, A | 1 |
| Encke, A | 1 |
| Stock, C | 1 |
| Dumke, HO | 1 |
| Dolmans, S | 1 |
| Olivier, J | 1 |
| Orban, JC | 1 |
| Mahieu, F | 1 |
| Kuramoto, A | 1 |
| Taketomi, Y | 1 |
| Nakagawa, J | 1 |
| Uchino, H | 1 |
| Castaldi, PA | 1 |
| Ben Ismail, M | 1 |
| Ghariani, M | 1 |
| Jais, JM | 1 |
| Hladovec, J | 3 |
| MacIomhair, M | 1 |
| Polterauer, P | 1 |
| Zekert, F | 1 |
| Gottlob, R | 1 |
| Harker, LB | 1 |
| Matsui, N | 1 |
| Gruel, Y | 1 |
| Lermusiaux, P | 1 |
| Lang, M | 1 |
| Darnige, L | 1 |
| Rupin, A | 1 |
| Delahousse, B | 1 |
| Guilmot, JL | 1 |
| Leroy, J | 1 |
| Ferlito, S | 1 |
| Lam, JY | 1 |
| Steele, PM | 1 |
| Heras, M | 1 |
| Webster, MW | 1 |
| Badimon, L | 1 |
| Mammen, EF | 1 |
| Müller, TH | 3 |
| Kraev, Z | 1 |
| Baldev, TS | 1 |
| Su, CA | 1 |
| Weisenberger, H | 1 |
| Brickl, R | 1 |
| Nehmiz, G | 1 |
| Sternon, J | 1 |
| Weber, E | 1 |
| Haas, TA | 1 |
| Buchanan, MR | 1 |
| Spácil, J | 1 |
| Nobuyoshi, M | 1 |
| Tanaka, M | 1 |
| Fujii, M | 1 |
| Asanuma, A | 1 |
| Takimoto, M | 1 |
| Rodríguez, V | 2 |
| Johannessen, KA | 1 |
| Taulow, E | 1 |
| Osterud, B | 1 |
| von der Lippe, G | 1 |
| Icenogle, TB | 1 |
| Smith, RG | 1 |
| Cleavinger, M | 1 |
| Vasu, MA | 1 |
| Williams, RJ | 1 |
| Sethi, GK | 1 |
| Copeland, JG | 1 |
| Sareli, P | 1 |
| England, MJ | 1 |
| Berk, MR | 1 |
| Marcus, RH | 1 |
| Epstein, M | 1 |
| Driscoll, J | 1 |
| Meyer, T | 1 |
| McIntyre, J | 1 |
| van Gelderen, C | 1 |
| Saitoh, H | 2 |
| Matsumoto, H | 1 |
| Ide, H | 1 |
| Miyawaki, F | 1 |
| Furuse, A | 1 |
| Escudero-Vela, MC | 1 |
| del Moral, JH | 1 |
| Mashburn, JP | 1 |
| McCarthy, PM | 1 |
| Gelman, JS | 1 |
| Mehta, J | 1 |
| Strano, A | 2 |
| Davì, G | 2 |
| Cannizzaro, S | 1 |
| Giubilato, A | 1 |
| Schmidt, SP | 1 |
| Hunter, TJ | 1 |
| Falkow, LJ | 1 |
| Evancho, MM | 1 |
| Sharp, WV | 1 |
| Hayashida, N | 1 |
| Niikura, H | 1 |
| Lane, I | 1 |
| Meek, A | 1 |
| Poskitt, K | 1 |
| McCollum, C | 1 |
| DeCampli, WM | 1 |
| Mitchell, RS | 1 |
| Handen, CE | 1 |
| Botindari, G | 1 |
| Catalano, I | 1 |
| Pinna, AD | 1 |
| Argiolu, F | 1 |
| Marongiu, L | 1 |
| Pinna, DC | 1 |
| Makhoul, RG | 1 |
| McCann, RL | 1 |
| Austin, EH | 1 |
| Greenberg, CS | 1 |
| Lowe, JE | 1 |
| Bonomini, V | 1 |
| Vangelista, A | 1 |
| Stefoni, S | 1 |
| Scolari, MP | 1 |
| Frascà, GM | 1 |
| Raimondi, C | 1 |
| Fujimoto, T | 1 |
| Yamazaki, H | 1 |
| Caine, I | 1 |
| Eldor, A | 1 |
| Kempczinski, RF | 1 |
| Ramalanjaona, GR | 1 |
| Douville, C | 1 |
| Silberstein, EB | 1 |
| Porath, A | 1 |
| Avnun, L | 1 |
| Hirsch, M | 1 |
| Ovsyshcher, I | 1 |
| Rosenthal, D | 1 |
| Mittenthal, MJ | 1 |
| Ruben, DM | 1 |
| Jones, DH | 1 |
| Estes, JW | 1 |
| Stanton, PE | 1 |
| Lamis, PA | 1 |
| Tartaglia, AP | 1 |
| Goldberg, JD | 1 |
| Berk, PD | 1 |
| Wasserman, LR | 1 |
| Di Perri, T | 1 |
| Findlay, JM | 1 |
| Lougheed, WM | 1 |
| Gentili, F | 1 |
| Walker, PM | 1 |
| Glynn, MF | 1 |
| Houle, S | 1 |
| Chandy, T | 1 |
| Sharma, CP | 1 |
| Piotrowski, JJ | 1 |
| Hashimoto, N | 1 |
| Marco, J | 1 |
| Silvernail, PJ | 1 |
| Fournial, G | 1 |
| Choy, DS | 1 |
| Fajadet, J | 1 |
| Case, RB | 1 |
| Danilov, IP | 1 |
| Makarevich, AE | 1 |
| Escolar, G | 1 |
| Bastida, E | 1 |
| Ordinas, A | 1 |
| Castillo, R | 1 |
| Harrison, MJ | 4 |
| Marshall, J | 1 |
| Meadows, JC | 1 |
| Russell, RW | 1 |
| Emmons, PR | 2 |
| Elkeles, RS | 1 |
| Hampton, JR | 2 |
| Prichard, JS | 2 |
| Markwardt, F | 1 |
| Diederen, W | 1 |
| Kadatz, R | 1 |
| Bensaid, J | 1 |
| Gerbaux, A | 1 |
| Scott, CR | 1 |
| Ross, R | 1 |
| Loew, D | 1 |
| Moschos, CB | 1 |
| Lahiri, K | 1 |
| Lyons, M | 1 |
| Weisse, AB | 1 |
| Oldewurtel, HA | 1 |
| Regan, TJ | 1 |
| Berger, KE | 1 |
| Mansfield, PB | 1 |
| Wood, SJ | 1 |
| Smith, JC | 1 |
| Overton, JB | 1 |
| Schnetzer, GW | 1 |
| Reuter, H | 1 |
| Hampton, J | 1 |
| Jenkins, CS | 1 |
| Zurro Hernández, J | 1 |
| Arribas Castrillo, JM | 1 |
| Durán García, S | 1 |
| Quintero de Juana, A | 1 |
| Romero, E | 1 |
| Adelson, E | 1 |
| Segal, A | 1 |
| Gordon, JL | 1 |
| George, CR | 1 |
| Quadracci, LJ | 1 |
| Striker, GE | 1 |
| Bove, LG | 1 |
| Bouvier, CA | 2 |
| Forbes, CD | 1 |
| Prentice, CR | 1 |
| Kahn, DR | 1 |
| Dufek, JH | 1 |
| Oberman, HA | 1 |
| Beck, ML | 1 |
| Bree, M | 1 |
| Kirsh, MM | 1 |
| Moores, WY | 1 |
| Prior, M | 1 |
| Bologna, E | 1 |
| Kummer, H | 1 |
| Attar, S | 1 |
| McLaughlin, JS | 1 |
| Masaitis, C | 1 |
| Hammond, GL | 1 |
| Bart, JB | 1 |
| Bounameaux, Y | 2 |
| Banks, DC | 1 |
| Justice, C | 1 |
| Papavangelou, E | 1 |
| Edwards, WS | 1 |
| Becker, RM | 1 |
| Smith, MR | 1 |
| Dobell, AR | 1 |
| Dziewolska, M | 1 |
| Krug, H | 1 |
| Laver, MC | 1 |
| Fairley, KF | 1 |
| Ponticelli, C | 1 |
| Imbasciati, E | 1 |
| Tarantino, A | 1 |
| Graziani, G | 1 |
| Redaelli, B | 1 |
| Giromini, M | 1 |
| Dami, R | 1 |
| Denizot, M | 1 |
| Jeannet, M | 1 |
| Heynen, U | 1 |
| Danese, CA | 1 |
| Haimov, M | 1 |
| Scharrer, I | 1 |
| Schepping, M | 1 |
| Bowie, EJ | 1 |
| Owen, CA | 1 |
| Gautier, JC | 1 |
| Derouesne, C | 1 |
| Held, T | 1 |
| Lhermitte, F | 1 |
| Stormorken, H | 1 |
| Perlick, E | 1 |
| Arfors, KE | 1 |
| Hint, HC | 1 |
| Dhall, DP | 1 |
| Matheson, NA | 1 |
| Gray, GR | 1 |
| Wilson, PA | 1 |
| Aznar, J | 1 |
| García-Conde Brú, J | 1 |
| Díaz, MC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency[NCT00067119] | Phase 3 | 649 participants (Actual) | Interventional | 2003-01-01 | Completed | ||
| Effect of Beraprost Sodium (Berasil) on Hemodialysis[NCT03142360] | 60 participants (Anticipated) | Interventional | 2017-04-05 | Recruiting | |||
| "Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel in Patients Undergoing One-stop Hybrid Coronary Revascularization"[NCT02513004] | Phase 4 | 60 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| A Placebo-Controlled, Double-Blind, Randomized Study of the Potential Interaction Between Aspirin and Ibuprofen or Celecoxib.[NCT00565500] | Phase 4 | 24 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311] | Phase 4 | 70 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337] | Phase 4 | 37 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [NCT00000527] | Phase 2 | 0 participants | Interventional | 1986-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| Arm 1 of 5 Randomized Treatment Arms | 27.6 |
| Arm 2 of 5 Randomized Treatment Arms | 27.0 |
| Arm 3 of 5 Randomized Treatment Arms | 31.4 |
| Arm 4 of 5 Randomized Treatment Arms | 25.7 |
| Arm 5 of 5 Randomized Treatment Arms | 28.3 |
Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| 1 of 5 Randomized Treatment Arms | 10.0 |
| 2 of 5 Randomized Treatment Arms | 11.2 |
| 3 of 5 Randomized Treatment Arms | 10.0 |
| 4 of 5 Randomized Treatment Arms | 11.0 |
| 5 of 5 Randomized Treatment Arms | 9.6 |
83 reviews available for dipyridamole and Thrombosis
| Article | Year |
|---|---|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Interventions for preventing thrombosis in solid organ transplant recipients.
Topics: Anticoagulants; Aspirin; Bias; Dipyridamole; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hum | 2021 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low | 2013 |
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vas | 2015 |
[Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
Topics: Cyclooxygenase Inhibitors; Dipyridamole; Humans; Iloprost; Platelet Aggregation; Platelet Aggregatio | 2009 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei | 2010 |
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Blood-Brain Barrier; Cilostazol; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy | 2010 |
Pharmacological modulation of vascular inflammation in atherothrombosis.
Topics: Atherosclerosis; Biomarkers; Dipyridamole; Endothelium; Humans; Inflammation Mediators; Models, Card | 2010 |
Anti-platelet therapy: phosphodiesterase inhibitors.
Topics: Blood Platelets; Cilostazol; Clinical Trials as Topic; Dipyridamole; Humans; Phosphodiesterase Inhib | 2011 |
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Cilostazol; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evid | 2012 |
Antiplatelet therapy in children: why so different from adults'?
Topics: Adult; Age Factors; Aspirin; Blood Platelets; Child Development; Child, Preschool; Dipyridamole; Hum | 2012 |
Dipyridamole in antithrombotic treatment.
Topics: Blood Platelets; Dipyridamole; Humans; Phosphodiesterase 5 Inhibitors; Platelet Aggregation Inhibito | 2012 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyrid | 2002 |
Antiplatelet agents in atherothrombotic diseases.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibit | 2004 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido | 2004 |
Antiplatelet drugs.
Topics: Animals; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Platelet Agg | 2006 |
[Update on antithrombotic treatments in arterial diseases].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifiba | 2007 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyrid | 2007 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Plate | 1983 |
Bleeding associated with antithrombotic therapy.
Topics: 4-Hydroxycoumarins; Aspirin; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic | 1980 |
Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery.
Topics: Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic A | 1983 |
[Pharmacology of anti-platelet agents].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Cyclic AMP; Cyclooxygenase Inhibitors; Dipyridamo | 1983 |
[Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inh | 1983 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; T | 1980 |
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Gastrointestina | 1981 |
The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Topics: Aspirin; Dipyridamole; Epoprostenol; Hemorrhage; Humans; Platelet Aggregation; Prostaglandins; Throm | 1980 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
Antiplatelet therapy.
Topics: Aspirin; Dipyridamole; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Tic | 1996 |
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Topics: Aspirin; Dipyridamole; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Pla | 1997 |
Dipyridamole: an unfulfilled promise?
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis Implantat | 1997 |
Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.
Topics: Anticoagulants; Child; Dipyridamole; Fontan Procedure; Heart Defects, Congenital; Heart Valve Prosth | 2001 |
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Female; Fibrinolytic Agents; Humans; Platelet Aggr | 2001 |
Aspirin in patients with coronary artery disease: is it simply irresistible?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Cor | 2001 |
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.
Topics: Adenosine Triphosphatases; Animals; Antigens, CD; Apyrase; Cyclooxygenase Inhibitors; Dipyridamole; | 2000 |
The role of prostacyclin in vascular tissue.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Coagulation; Blood Platelets; Blood Vessels; Cyclic AMP; | 1979 |
[Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
Topics: Aspirin; Coumarins; Dextrans; Dipyridamole; Heart Valve Prosthesis; Heparin; Humans; Lipids; Platele | 1977 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Dis | 1978 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
[Prophylaxis of thromboembolism using low dosage heparin (author's transl)].
Topics: Antithrombins; Aspirin; Blood Coagulation; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; | 1979 |
[Thrombosis prevention and platelet functions following heart valve replacement].
Topics: Adult; Anticoagulants; Aspirin; Blood Flow Velocity; Blood Platelets; Dipyridamole; Female; Heart Va | 1978 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; | 1979 |
Platelet and fibrinogen kinetic evaluation of thrombogenesis.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; F | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thro | 1979 |
[State of thrombosis risk: diagnostic and preventive possibilities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Risk; Sulfinpyrazone; Thrombosi | 1979 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platele | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelets and thrombosis.
Topics: Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Humans; Thrombosis | 1976 |
[Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Topics: Anticoagulants; Aspergillus; Aspirin; Brinolase; Coumarins; Dipyridamole; Disseminated Intravascular | 1975 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyrida | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Dose-Response Relationship, Drug; | 1992 |
Consultation section. Attitudes regarding the concomitant use of anti-coagulants with elective cataract surgery.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Cataract Extraction; Contraindications; Dipyridamole; Ey | 1992 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery | 1991 |
An overview of dipyridamole.
Topics: Animals; Dipyridamole; Humans; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Thrombosis | 1990 |
[Current aspects of arterial anti-thrombosis prophylaxis].
Topics: Adult; Aged; Aspirin; Contraindications; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; P | 1990 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin | 1985 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
[Thrombosis in various diseases: myocardial infarct].
Topics: Angioplasty, Balloon; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Th | 1986 |
[Thrombosis in various diseases: myeloproliferative disorders].
Topics: Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Busulfan; Carbazilquinone; Dipyridamole; H | 1986 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Collagen; Coronary Artery Bypass | 1985 |
[Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazo | 1988 |
[Thrombosis in various diseases: arteriosclerosis and thrombosis].
Topics: Animals; Arteriosclerosis; Aspirin; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1986 |
[Dipyridamole].
Topics: Dipyridamole; Humans; Thrombosis | 1986 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topi | 1974 |
Platelets and thrombogenesis--current concepts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Coagulation; Blood Platelets; Clot Retraction; | 1972 |
[Aggregation inhibitors. The inhibition of platelet function by means of chemical substances].
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Aspirin; Blood Proteins; Calcium; Collagen; Dipyridamole; | 1973 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Dis | 1971 |
Trends in the development of antithrombotic agents.
Topics: Adenine Nucleotides; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticoagulants; As | 1971 |
The prevention of thrombosis.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Coumarins; Dipyridamole; Heparin; Humans; Platele | 1974 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor V | 1974 |
41 trials available for dipyridamole and Thrombosis
| Article | Year |
|---|---|
Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Heart Failure; Heart-Assist Devices; Heparin; Heparin, | 2008 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; | 2009 |
Use of aspirin associates with longer primary patency of hemodialysis grafts.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Chronic | 2011 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; C | 2003 |
Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Topics: Adolescent; Adult; Arteries; Aspirin; Clopidogrel; Collagen; Cross-Over Studies; Delayed-Action Prep | 2005 |
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
Topics: Acetylation; Aspirin; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Dipyridamole; Humans | 1982 |
Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamol | 1983 |
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary | 1983 |
[The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agen | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inh | 1983 |
Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
Topics: Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Drug Combinati | 1983 |
Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Topics: Aged; Aspirin; Dipyridamole; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; P | 1984 |
Platelet inhibitory drugs: an in vivo method of evaluation in patients.
Topics: Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Double-B | 1982 |
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Bl | 1982 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
Secondary prevention of myocardial infarction--the present state of the ART.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial | 1980 |
Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
[The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Postoperative Co | 1981 |
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Topics: Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Postop | 1982 |
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamol | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; | 1994 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trial | 1977 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
[Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
Topics: Adenosine Diphosphate; Adult; Arteriovenous Shunt, Surgical; Blood Coagulation Disorders; Blood Plat | 1976 |
[Double-blind study for the prevention of postoperative thrombosis].
Topics: Abdomen; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Thrombosi | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Double-Blind Method; Drug Interactions; Endothelium, | 1990 |
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.
Topics: Aspirin; Blood Coagulation; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therap | 1989 |
Thromboembolic complications of the Symbion AVAD System.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Equipment Design; Heart-Assist De | 1989 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyr | 1987 |
A comparison of the effects of a thromboxane antagonist and cyclo-oxygenase inhibitor on platelet accumulation in arterial grafts.
Topics: Aorta; Aspirin; Biphenyl Compounds; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibi | 1987 |
Platelet-inhibitory therapy in reconstructive arterial surgery.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Bli | 1985 |
Use of defibrotide in renal transplantation in man.
Topics: Clinical Trials as Topic; Dipyridamole; Fibrinolytic Agents; Graft Rejection; HLA Antigens; Humans; | 1986 |
Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
Topics: Aged; Aspirin; Blood Platelets; Carotid Arteries; Carotid Artery Diseases; Cerebrovascular Disorders | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topi | 1974 |
200 other studies available for dipyridamole and Thrombosis
| Article | Year |
|---|---|
Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines.
Topics: Animals; Cats; Collagen; Dihydropyridines; Humans; Kinetics; Male; Mice; Nitrendipine; Platelet Aggr | 1988 |
P-Selectin mediates targeting of a self-assembling phototherapeutic nanovehicle enclosing dipyridamole for managing thromboses.
Topics: Animals; Dipyridamole; Nanoparticles; P-Selectin; Phototherapy; Polymers; Pyrroles; Thrombosis | 2023 |
New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Betacoronavirus; Coronavirus Infections; COVID-19; CO | 2020 |
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
Topics: Adenosine A2 Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; C | 2020 |
Fused deposition modelling for the development of drug loaded cardiovascular prosthesis.
Topics: Anti-Bacterial Agents; Blood Cells; Blood Vessel Prosthesis; Delayed-Action Preparations; Dipyridamo | 2021 |
Autoantibodies May Drive COVID-19 Blood Clots.
Topics: Autoantibodies; COVID-19; COVID-19 Drug Treatment; Dipyridamole; Humans; Platelet Aggregation Inhibi | 2021 |
Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cyclic GMP; Dipyridamole; Diseas | 2013 |
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Topics: Adult; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Dipyridamole; Disease-Free Survival; | 2016 |
Antiplatelet therapy and vascular-access patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vasc | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; General Surgery; Graft Oc | 2009 |
Aspirin and arteriovenous graft thrombosis in hemodialysis: just what the doctor ordered?
Topics: Arteriovenous Shunt, Surgical; Aspirin; Chronic Disease; Dipyridamole; Humans; Kidney Diseases; Plat | 2011 |
Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
Topics: Cerebral Infarction; Dipyridamole; Drug Eruptions; Humans; Hypersensitivity, Delayed; Male; Middle A | 2012 |
Antiplatelet drugs.
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein G | 2003 |
[Clinico-experipyrimido (5,4-d) pyrimidine].
Topics: Angina Pectoris; Dipyridamole; Heart Diseases; Humans; Intracranial Embolism; Intracranial Embolism | 1963 |
[Thrombocytic dysfunctions and potentialities of their differential correction in chronic viral hepatitis].
Topics: Adolescent; Adult; Antiviral Agents; Blood Platelets; Chronic Disease; Dipyridamole; Female; Hepatit | 2004 |
The effect of dipyridamole on vascular cell-derived reactive oxygen species.
Topics: Antioxidants; Blood Platelets; CD40 Antigens; Cells, Cultured; Coloring Agents; Dipyridamole; Endoth | 2005 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
Topics: Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Recurrence; | 1980 |
Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Hepari | 1983 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; He | 1983 |
The effect of dipyridamole and warfarin on the patency rate of coronary artery bypass grafts.
Topics: Adult; Blood Vessel Prosthesis; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle A | 1983 |
Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Endothelium; Evaluation Studies as To | 1982 |
The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Topics: Arteries; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination | 1984 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxy | 1980 |
Prevention of platelet aggregation in patients with prostatic cancer during estrogen therapy.
Topics: Aged; Blood Coagulation Tests; Blood Platelets; Cyclic AMP; Dipyridamole; Fibrinolysis; Hexestrol; H | 1982 |
Antithrombotic activity and the mechanism of action of trapidil (Rocornal).
Topics: Adenosine Triphosphate; Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Disease | 1982 |
The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dipyridamole; Epoprostenol; Fibrinolytic Agents; Mal | 1983 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregatio | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; | 1984 |
Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
Topics: Aspirin; Blood Circulation; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Humans; Methods; | 1980 |
[Thrombus formation and its prevention during extracorporeal circulation--effect of preoperative administration with the antiplatelet drugs].
Topics: Adult; Dipyridamole; Extracorporeal Circulation; Humans; Microscopy, Electron, Scanning; Platelet Ad | 1984 |
Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Gastric Acidity Determination; Gastric Mucosa; Hepar | 1983 |
The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography.
Topics: Adult; Aged; Anticoagulants; Aspirin; Dipyridamole; Echocardiography; Heart Ventricles; Humans; Indi | 1984 |
Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
Topics: Adult; Aspirin; Blood Platelets; Cellulose; Dipyridamole; Double-Blind Method; Female; Humans; Male; | 1984 |
[Use of calciparin, curantyl and polopirin S in the treatment of retinal vein thrombosis].
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; | 1984 |
[Blood coagulation processes in decompression sickness and hyperbaric therapy].
Topics: Antioxidants; Arachidonic Acid; Arachidonic Acids; Blood Coagulation Disorders; Decompression Sickne | 1981 |
Comparison of the antithrombotic action of calcium antagonist drugs with dipyridamole in dogs.
Topics: Animals; Blood Platelets; Calcium Channel Blockers; Dipyridamole; Disease Models, Animal; Dogs; Fibr | 1983 |
Veno-venous allografts: patency, subendothelial proliferation, and the role of platelet-active agents.
Topics: Animals; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Dogs; Female; Graft Survival; Male; | 1983 |
Antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Humans; Sulfinpyrazone; | 1983 |
Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.
Topics: Adult; Aspirin; Blood Platelets; Dermatomyositis; Dipyridamole; Female; Humans; Sulfinpyrazone; Thro | 1983 |
The effect of antiaggregating drugs on the patency of grafts in the arterial system.
Topics: Animals; Anticoagulants; Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Erg | 1980 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Caroti | 1980 |
Gore-Tex (polytetrafluoroethylene) in canine coronary artery bypass.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Blood Vessel Prosthesis; Coronary Angiography; Coronary Art | 1980 |
Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
Topics: Animals; Aspirin; Coronary Artery Bypass; Dipyridamole; Dogs; Femoral Vein; Thrombosis | 1981 |
[Platelet aggregation inhibitors].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Dipyridamole; Humans; Platelet Aggregatio | 1981 |
The anti-thrombotic effects of prostacyclin.
Topics: Animals; Arteries; Aspirin; Cardiovascular Diseases; Dipyridamole; Epoprostenol; Fatty Acids; Hemost | 1980 |
Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Cell Adhesion; Dipyridamole; Endothelium; Epoprostenol; In | 1982 |
Aspirin to prevent arterial thrombosis.
Topics: Arteries; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Thrombosis | 1982 |
[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Ischemic Attack, Transient; M | 1982 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Conge | 1982 |
Evaluation of platelet-inhibitor drugs in a canine bilateral femoral graft implant model.
Topics: Animals; Blood Platelets; Blood Vessel Prosthesis; Calcium Channel Blockers; Dipyridamole; Dogs; Fem | 1982 |
Scanning electron microscopic and X-ray energy spectrographic analysis of the inner surface of human atherosclerotic carotid plaques.
Topics: Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Dipyridamole; Female; Humans; Intracrani | 1981 |
Platelet adhesiveness: methodology for testing in humans.
Topics: Arterial Occlusive Diseases; Cell Survival; Densitometry; Diabetes Mellitus; Dipyridamole; Humans; I | 1981 |
[Thrombocytosis. Considerations on a case with intestinal thrombosis diagnosed at the age of 4 months and treated with platelet anti-aggregants].
Topics: Aspirin; Dipyridamole; Female; Humans; Infant; Intestinal Diseases; Thrombocytosis; Thrombosis | 1981 |
Prevention of thrombosis with antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1980 |
[The value of anti-thrombosis agents in acute peripheral obstructions in the extremities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Embolism; Fibrinolytic Agents; Humans; Streptokinase; Thrombo | 1980 |
Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Dipyridamole; Femoral Artery; Femoral Vein; Fibrinolytic Agents | 1995 |
CarboMedics valve in congenital heart disease. Midterm follow-up study of 14 patients.
Topics: Aortic Valve; Aspirin; Child; Dipyridamole; Female; Follow-Up Studies; Heart Defects, Congenital; He | 1994 |
Thrombolytic therapy of renal vein thrombi and follow-up.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Female; Follow-Up Studies; Humans | 1994 |
Thrombotic obstruction of bileaflet valves: surgical management and fiberoptic thrombectomy.
Topics: Dipyridamole; Emergencies; Endoscopy, Digestive System; Fiber Optic Technology; Heart Valve Prosthes | 1994 |
Prevention of thrombus formation on biomaterials exposed to blood using different antiplatelet drugs: experimental study in dogs.
Topics: Animals; Aspirin; Biocompatible Materials; Blood; Dipyridamole; Dogs; Indium Radioisotopes; Male; Pl | 1994 |
[No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Complications; | 1993 |
Occlusion of the superior mesenteric artery in a patient with polycythemia vera: resolution with percutaneous transluminal angioplasty.
Topics: Angioplasty, Balloon; Dipyridamole; Humans; Male; Mesenteric Artery, Superior; Mesenteric Vascular O | 1996 |
In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis.
Topics: Animals; Aspirin; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cerebrov | 1996 |
Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals.
Topics: Animals; Aspirin; Blood Coagulation; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Ell | 1996 |
Portal vein thrombosis associated with antiphospholipid antibodies in a child.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Child, Preschool; Dipyridamole; Esophageal a | 1996 |
Photo-immobilization of dipyridamole (Persantin) at the surface of polyurethane biomaterials: reduction of in-vitro thrombogenicity.
Topics: Biocompatible Materials; Blood Platelets; Dipyridamole; Drug Carriers; Humans; In Vitro Techniques; | 1997 |
Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Endothelium, Vascular; Femoral Vein; Hepar | 1996 |
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation | 1997 |
Degos disease in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male; | 1998 |
[Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
Topics: Adult; Aspirin; Bone Marrow Transplantation; Dipyridamole; Female; Humans; Leukemia, Myeloid, Acute; | 2000 |
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relations | 2000 |
Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Carotid Arteries; Coated Mat | 2001 |
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterization.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Proteins; Cellulose; Dipyridamole; Dogs; Female; | 1979 |
Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
Topics: Blood Platelets; Clofibrate; Collagen; Dipyridamole; Heparin; Humans; Peroxides; Prospective Studies | 1977 |
Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Aspirin; Child; Dipyridamole; Female; Homozygote; Humans; Hypercholesterolemia; M | 1976 |
Degos' disease treated with platelet-suppressive drugs.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Male; Skin; Skin Diseases; Syndrome | 1977 |
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Depression, Chemical; Dipyridamole; Do | 1978 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso | 1975 |
Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.
Topics: Adult; Aprotinin; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Concanavalin A; Dipyri | 1979 |
The effects of anti-thrombotic therapy in renal disease.
Topics: Blood Platelets; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Glomerulonephritis; Graft | 1979 |
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function.
Topics: Aged; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Blood Vessel Prosthesi | 1977 |
[Therapy and prevention of acute phlebothrombosis with heparin, coumarins and inhibitors of platelet function].
Topics: Coumarins; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Heparin; Humans; Platelet Aggre | 1979 |
Impending central retinal vein occlusion associated with increased platelet aggregability.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Dipyridamole; | 1979 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocard | 1979 |
Near fatal puerperal thrombosis on Björk-Shiley mitral valve prosthesis.
Topics: Dipyridamole; Female; Heart Valve Prosthesis; Heparin; Humans; Mitral Valve; Pregnancy; Pregnancy Co | 1979 |
Effects of heparin, aspirin and dipyridamole on thrombus formation on venous catheters.
Topics: Animals; Aspirin; Catheterization; Dipyridamole; Disease Models, Animal; Face; Heparin; Polyethylene | 1979 |
Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Citrates; Dipyridamole; Dose-Response Relationship | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Att | 1979 |
Inhibitors of platelet function and atherogenesis.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Humans; P | 1979 |
[Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects].
Topics: Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Phthalazines; Platelet | 1979 |
Hypercoagulability: a cause of vascular access failure.
Topics: Antithrombin III Deficiency; Aspirin; Dipyridamole; Humans; Intraoperative Period; Plasma; Renal Dia | 1979 |
[Prevention and therapy with anticoagulants. Indications, experiences, results].
Topics: Anticoagulants; Aspirin; Blood Coagulation; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; | 1979 |
Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats.
Topics: Animals; Aspirin; Dipyridamole; Imidazoles; Male; Pyridines; Rats; Thrombosis | 1978 |
[Platelet-inhibiting drugs].
Topics: Anti-Bacterial Agents; Aspirin; Dextrans; Dipyridamole; Hemorrhage; Humans; Indomethacin; Platelet A | 1978 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofi | 1978 |
[Correction of disorders of rheologic properties of blood in reconstructive operations on the abdominal aorta].
Topics: Adult; Aged; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Aspirin; Blood Viscosity; Dipyrida | 1978 |
Platelet survival time: its measurement and use.
Topics: Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; Heparin; H | 1978 |
Malignant atrophic papulosis: treatment with aspirin and dipyridamole.
Topics: Adult; Aspirin; Dipyridamole; Humans; Infarction; Male; Platelet Aggregation; Skin; Skin Diseases; T | 1978 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; D | 1979 |
[Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Dextrans; Dipyridamole; Hemorrhagic Disorder | 1977 |
The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels.
Topics: Adenosine Diphosphate; Alloxan; Animals; Aspirin; Dipyridamole; Drug Synergism; Male; Platelet Aggre | 1977 |
The role of the platelet in coagulation and clinical thrombotic events.
Topics: Blood Coagulation; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dipy | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1977 |
[Clinical effect of dipyridamole ingestion after prosthetic heart valve replacement--especially on the blood coagulation system (author's transl)].
Topics: Adolescent; Adult; Blood Coagulation; Blood Viscosity; Dipyridamole; Female; Heart Valve Diseases; H | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Regional administration of drugs to control thrombosis in artificial organs.
Topics: Adenosine; Animals; Artificial Organs; Blood Cell Count; Blood Coagulation; Blood Platelets; Dipyrid | 1976 |
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole.
Topics: Animals; Aspirin; Dipyridamole; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic A | 1976 |
[Surgical treatment and prevention of acute deep venous thrombosis].
Topics: Aged; Dextrans; Dipyridamole; Hemorrhage; Heparin; Humans; Middle Aged; Pulmonary Embolism; Thrombop | 1976 |
Review of 1,375 cases of vascular reconstruction for ischemic disorder of the lower limbs Statistical analysis of late postoperative thromboses with evaluation of the effect of an anti-platelet agent[tauthor's transl)].
Topics: Arteriosclerosis Obliterans; Dipyridamole; Follow-Up Studies; Humans; Leg; Middle Aged; Platelet Adh | 1976 |
Metabolic and kinetic study of thrombogenesis: regulatory mechanism in early step of platelet plug formation.
Topics: Adult; Aged; Blood Platelets; Dipyridamole; Epinephrine; Female; Glycolysis; Humans; Leukemia, Myelo | 1976 |
Prophylactic agents for thrombosis.
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Platelet Aggregation; Thr | 1975 |
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Hum | 1975 |
The effect of some antithrombotic drugs on experimental arterial thrombosis.
Topics: Acute Disease; Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Drug Synergism; Fibrinolysi | 1975 |
Proceedings: The anti-thrombotic effect of warfarin, dipyridamole and aspirin in the rat.
Topics: Animals; Aspirin; Dipyridamole; Disease Models, Animal; Rats; Thrombosis; Warfarin | 1975 |
[Acetylsalicylic acid and dipyridamole: aggregation inhibition in the rabbit experiment].
Topics: Administration, Oral; Animals; Aspirin; Dipyridamole; Drug Therapy, Combination; Injections, Intrave | 1975 |
Pharmacological properties of drug inhibiting platelet aggregation.
Topics: Aspirin; Dipyridamole; Humans; In Vitro Techniques; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1975 |
[Renal vein thrombosis].
Topics: Dipyridamole; Heparin; Humans; Nephrotic Syndrome; Renal Veins; Thrombosis; Urokinase-Type Plasminog | 1992 |
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
Topics: Aged; Aorta, Abdominal; Aspirin; Dipyridamole; Female; Femoral Vein; Heparin; Humans; Iliac Artery; | 1991 |
Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
Topics: Angioplasty, Balloon; Animals; Arteries; Aspirin; Dipyridamole; Fibrinolytic Agents; Heart Diseases; | 1991 |
Dipyridamole--evaluation of an established antithrombotic drug in view of modern concepts of blood cell-vessel wall interactions.
Topics: Animals; Blood Vessels; Cholesterol, Dietary; Cricetinae; Dipyridamole; Disease Models, Animal; Endo | 1990 |
[The drug prevention of thrombotic complications of the vascular approach--arteriovenous fistulae and synthetic prostheses in patients on hemodialysis with antistenocardin].
Topics: Adolescent; Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis; Child; Dip | 1990 |
Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenicity following injury: influence of salicylate and dipyridamole treatment.
Topics: Animals; Carotid Arteries; Dipyridamole; Endothelium, Vascular; Linoleic Acids; Platelet Adhesivenes | 1990 |
[How important is dipyridamole in patients with ischemic heart disease?].
Topics: Coronary Disease; Dipyridamole; Humans; Thrombosis | 1990 |
Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits.
Topics: Angioplasty, Balloon; Animals; Aorta; Arteriosclerosis; Azepines; Body Weight; Cholesterol; Dilazep; | 1989 |
[Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
Topics: Animals; Aspirin; Dipyridamole; Dogs; Drug Evaluation; Drug Therapy, Combination; Platelet Aggregati | 1989 |
Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses.
Topics: Adolescent; Adult; Anticoagulants; Birth Weight; Blood Coagulation; Dipyridamole; Female; Fetus; Hea | 1989 |
[Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
Topics: Adult; Aged; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggre | 1989 |
Prevention of the formation of arterial thrombi using different antiplatelet drugs: experimental study in dogs.
Topics: Animals; Aspirin; Dipyridamole; Dogs; Indium Radioisotopes; Platelet Aggregation Inhibitors; Salicyl | 1989 |
Thrombogenicity of canine free internal mammary artery autografts.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Dogs; Fibrinogen; Kinetics; | 1989 |
The antithrombotic in vivo effect of eterylate and dipyridamole in experimental thrombosis in mice.
Topics: Acetanilides; Animals; Anticoagulants; Dipyridamole; Drug Therapy, Combination; Male; Mice; Platelet | 1986 |
Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model.
Topics: Animals; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridam | 1985 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; | 1986 |
Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.
Topics: Animals; Aspirin; Cholesterol, Dietary; Cod Liver Oil; Dipyridamole; Dogs; Elastic Tissue; Endotheli | 1988 |
[Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].
Topics: Blood Platelets; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet A | 1988 |
Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
Topics: Aspirin; Blood Transfusion; Cerebrovascular Disorders; Child; Dipyridamole; Female; Follow-Up Studie | 1988 |
Effect of naftidrofuryl and dipyridamole on laser-induced thrombosis in rat mesenteric vessels.
Topics: Animals; Dipyridamole; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Male; Mesen | 1987 |
Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery.
Topics: Adult; Aged; Aspirin; Cardiopulmonary Bypass; Coronary Artery Bypass; Dipyridamole; Emergencies; Fem | 1987 |
Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Fibronectins; Platelet Adhesiveness; | 1987 |
Right atrial thrombus and recurrent pulmonary emboli secondary to permanent cardiac pacing--a case report and short review of literature.
Topics: Aged; Aged, 80 and over; Dipyridamole; Female; Heart Atria; Heart Diseases; Heparin; Humans; Pacemak | 1987 |
The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Arteriovenous Shunt, Surgical; Aspirin; | 1987 |
Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
Topics: Aspirin; Dipyridamole; Female; Hemorrhage; Humans; Male; Phosphorus Radioisotopes; Platelet Aggregat | 1986 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |
Protein/platelet interaction with an artificial surface: effect of vitamins and platelet inhibitors.
Topics: Adsorption; Amino Sugars; Animals; Aspirin; Blood Platelets; Blood Proteins; Cattle; Dipyridamole; F | 1986 |
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
Topics: Animals; Anticoagulants; Aspirin; Capillaries; Dipyridamole; Gastric Mucosa; Male; Platelet Aggregat | 1985 |
[Does dipyridamole (Persantin) have antithrombotic action?].
Topics: Dipyridamole; Fibrinolytic Agents; Humans; Thrombosis | 1985 |
[Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
Topics: Adult; Anticoagulants; Blood Coagulation; Dipyridamole; Female; Heart Valve Diseases; Heart Valve Pr | 1985 |
Complete patency in thrombus-occluded arteries two weeks after laser recanalization.
Topics: Animals; Aspirin; Dipyridamole; Dogs; Femoral Artery; Laser Therapy; Thrombosis; Time Factors | 1985 |
[Correction of hemorheological disorders in patients with chronic obstructive bronchitis].
Topics: Adult; Blood Viscosity; Bronchitis; Dipyridamole; Hemodilution; Humans; Middle Aged; Thrombosis | 1985 |
Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
Topics: Adenosine Triphosphate; Adult; Animals; Aorta, Abdominal; Aspirin; Blood Platelets; Chymotrypsin; Di | 1985 |
Management of thrombosis.
Topics: Administration, Oral; Antibody Formation; Anticoagulants; Coumarins; Dipyridamole; Drug Synergism; F | 1971 |
Effect of aspirin in amaurosis fugax.
Topics: Aspirin; Blindness; Dipyridamole; Recurrence; Retinal Vessels; Thrombosis | 1971 |
Effect of dipyridamole on human platelet behaviour.
Topics: Adenine Nucleotides; Animals; Blood Coagulation; Blood Platelets; Dipyridamole; Humans; In Vitro Tec | 1965 |
Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo.
Topics: Adenine Nucleotides; Animals; Blood Coagulation; Blood Platelets; Dipyridamole; Electrophoresis; Nor | 1968 |
Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.
Topics: Anticoagulants; Cadaver; Dipyridamole; Graft vs Host Reaction; Heparin; Humans; Kidney; Kidney Glome | 1969 |
[The effect of drugs on platelet function].
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Blood Platelets; Cell Membrane Permeability; | 1969 |
[The inhibition of thrombocyte aggregation in vitro and in vivo].
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Fatty Acids, Es | 1969 |
Local oxygen tension and blood flow in the normal and chronic ischemic myocardium in the anesthetized dog.
Topics: Anesthesia, Intravenous; Animals; Chloralose; Collateral Circulation; Constriction; Coronary Circula | 1973 |
[Late dysfunction of mitral valve prosthesis due to thrombosis. Its detection and the practical attitude required].
Topics: Aged; Amplifiers, Electronic; Anticoagulants; Cardiac Catheterization; Dipyridamole; Electrocardiogr | 1974 |
Homocystinemia. Vascular injury and arterial thrombosis.
Topics: Adolescent; Adult; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Vessels; Dip | 1974 |
Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.
Topics: Animals; Aspirin; Blood Platelets; Chromium Isotopes; Coronary Circulation; Coronary Disease; Dipyri | 1973 |
Future directions in the development of arterial prostheses for small and medium caliber arteries.
Topics: Animals; Arteries; Aspirin; Blood Flow Velocity; Blood Vessel Prosthesis; Dipyridamole; Endothelium; | 1974 |
The pathogenesis of the vascular and glomerular lesions of rejection in renal allografts and their modification by antithromtotic and anticoagulant drugs.
Topics: Blood Vessels; Dipyridamole; Graft vs Host Reaction; Heparin; Humans; Kidney; Kidney Transplantation | 1970 |
Modification of platelet function.
Topics: Animals; Antigen-Antibody Complex; Aspirin; Blood Coagulation; Blood Platelets; Calcium; Cell Moveme | 1972 |
[Prophylaxis of thrombogenesis in the diabetic patient].
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Drug Evaluation; Humans; Platel | 1974 |
Antithrombotic drugs and experimental thrombosis.
Topics: Animals; Aspirin; Dextrans; Dipyridamole; Disease Models, Animal; Drug Combinations; Fibrinolytic Ag | 1972 |
Editorial: Anticoagulation IV: Preventing thrombosis by modifying platelet behavior.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Hemorrhagic Disor | 1974 |
Treatment of arterial lesions in cardiac allografts.
Topics: Animals; Cats; Coronary Disease; Dipyridamole; Graft Rejection; Guinea Pigs; Heart Transplantation; | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin | 1974 |
The effect of heparin and dipyridamole on chronic vascular lesions in monkey cardiac allografts.
Topics: Animals; Azathioprine; Dipyridamole; Female; Haplorhini; Heart Transplantation; Heparin; Macaca; Mal | 1972 |
Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Cerebral Arteries; Dipyridamole; | 1972 |
Influence of some drugs on platelet aggregation: a study in hypertensive patients.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Blood Cell Count; Blood | 1972 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intrav | 1972 |
[New possibilities in the prevention of thrombosis].
Topics: Aspirin; Dextrans; Dipyridamole; Heparin; Humans; Thrombosis | 1973 |
Clinical application of platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Dipyridamole; Epinephrine; Humans; Intracranial Emb | 1973 |
Dipyridamole and aspirin tested against an experimental model of thrombosis.
Topics: Animals; Aspirin; Blood Vessels; Dipyridamole; Disease Models, Animal; Dogs; Hematoma; Hemorrhagic D | 1973 |
Preventing thrombosis.
Topics: Aspirin; Dipyridamole; Humans; Thrombosis | 1973 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thromboph | 1973 |
Leucocytes and thrombosis. 3. Effect on white cell behaviour of substances which induce or inhibit platelet aggregation.
Topics: Adenosine; Aspirin; Catecholamines; Collagen; Dipyridamole; Epinephrine; Isoproterenol; Leukocytes; | 1973 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
Prevention of thrombosis with agents which reduce platelet adhesiveness.
Topics: Animals; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Dogs; Femoral Artery; Molecular Weight; Pl | 1974 |
Effect of platelet inhibition on platelet phenomena in cardiopulmonary bypass in pigs.
Topics: Animals; Blood Cell Count; Blood Flow Velocity; Blood Platelets; Carbon Dioxide; Dipyridamole; Extra | 1974 |
[Role of thrombotic agent in coronary insufficiency--therapeutic implications (author's transl)].
Topics: Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; | 1974 |
Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy.
Topics: Acute Kidney Injury; Adolescent; Adult; Anticoagulants; Collagen Diseases; Coumarins; Dipyridamole; | 1970 |
Post-partum renal failure with microangiopathic haemolytic anaemia. Long-term survival after anticoagulant therapy.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Anticoagulants; Blood Platelet Disorders; Cesarean Se | 1972 |
Effect of dipyridamole and aspirin in thrombotic microangiopathy.
Topics: Adult; Anemia, Hemolytic; Aspirin; Dipyridamole; Humans; Male; Platelet Adhesiveness; Purpura, Throm | 1972 |
[Persantin: coronary insufficiency, prevention of thrombosis, kidney failure, intrauterine asphyxia].
Topics: Animals; Asphyxia Neonatorum; Attitude; Coronary Circulation; Coronary Disease; Dipyridamole; Female | 1972 |
Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
Topics: Administration, Oral; Animals; Aspirin; Blood Cell Count; Blood Platelets; Carotid Arteries; Cyprohe | 1971 |
[Pharmacodynamic prevention of thrombosis].
Topics: Adenosine Diphosphate; Amitriptyline; Anticoagulants; Aspirin; Collagen; Dipyridamole; Guanethidine; | 1971 |
[Prevention of thrombosis using aspirin? nfluence of acetylsalicylic acid on thrombocyte aggregation in vitro and in vivo].
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Dipyridamole; Female; Humans; Middle Aged; Papave | 1969 |
Inhibition of arterial thrombosis and platelet adhesiveness in the rat by intravenous 2,4,6-trimorpholinopyrimido-(5,4-d)-pyrimidine (RA 433).
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Blood Platelets; Blood Pressure; Dipyri | 1970 |
[Experimental blood platelet thrombosis in cerebral arteries. Effects of dipyridamole, ergot derivatives and antiserotonin agents].
Topics: Animals; Blood Platelets; Cerebral Arterial Diseases; Cerebral Arteries; Cerebrovascular Circulation | 1970 |
[Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
Topics: Animals; Aspirin; Coronary Disease; Dipyridamole; Humans; Thrombophlebitis; Thrombosis | 1971 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nuc | 1968 |
Counteraction of platelet activity at sites of laser-induced endothelial trauma.
Topics: Animals; Arteries; Blood Platelets; Depression, Chemical; Dextrans; Dipyridamole; Ear, External; Hep | 1968 |
The effect on dipyridamole on platelet aggregation and adhesiveness.
Topics: Adenine Nucleotides; Adult; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Thromb | 1968 |
Inhibition by dipyridamole of arterial thrombosis in rats.
Topics: Animals; Aspirin; Dipyridamole; Heparin; Mesenteric Arteries; Rats; Thrombosis; Warfarin | 1968 |
[Antithrombotic effect of dipyridamole].
Topics: Blood Platelets; Dipyridamole; Humans; In Vitro Techniques; Thrombosis | 1968 |
Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.
Topics: Animals; Dipyridamole; Female; Humans; Male; Rabbits; Thrombosis; Wounds and Injuries | 1965 |